Breast Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Therapy Type (Targeted therapy, Chemotherapy, Surgery & Radiation Therapy, Hormonal therapy); By Region, Segments & Forecast, 2018 - 2026

Report Summary

The global breast cancer therapeutics market was valued at USD 14.2 billion in 2017 and is anticipated to grow at a CAGR of 10.3% during the forecast period. Brest cancer is a type of cancer developing in the breast tissue. The common indication of breast cancer includes red patches and formation of lump in breast on the skin. Some of the risk factors for developing breast cancer are overexposure to radiation, obesity, lack of physical exercise, and high consumption of alcohol.

According to the reports of The National Cancer Institute approximately 246,660 cases of breast cancer were diagnosed during 2016. The rising prevalence rate and increasing occurrence of breast cancer are major factors boosting the global breast cancer therapeutics market growth. Currently, several breast cancer awareness programs for early detection and treatments are held in several emerging nations across Asia Pacific and Latin America which is further anticipated to generate the market opportunities in the market. It is believed that with such initiatives including early diagnosis and treatment, the demand for global breast cancer therapies is expected to increase along with factors such as pharmacology promoting drug development, high investment in R&D and advancements in oncology.

Global Breast Cancer therapeutics Market Share, By Therapy Type, 2017 - 2026

Know more about this report:样本页请求

Segment Analysis

The global breast cancer therapeutics Market is segmented on the basis of therapy type and region. On the basis of therapy type, the market is categorized into targeted therapy, chemotherapy, surgery & radiation therapy, and hormonal therapy.

Breast Cancer Therapeutics Market Scope

By Therapy Type	By Region
Targeted therapy Chemotherapy Surgery & radiation therapy Hormonal therapy	North America (U.S., Canada) Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands) Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines) Latin America (Brazil, Mexico, Argentina) 中东和非洲(阿拉伯联合酋长国、沙特阿拉伯、韩国frica)

Know more about this report:样本页请求

Regional Analysis

《乳腺癌治疗市场报告》详细介绍了北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区的市场地理分布。北美分为美国、加拿大和墨西哥。欧洲地区包括德国、英国、法国和意大利。亚太地区进一步分为中国、印度、日本。从地理位置来看，北美乳腺癌治疗市场占有最大的市场份额。导致该地区市场高速增长的主要因素包括乳腺癌的高发病率、政府福利的增加和老年女性人口基数的增加。此外，诊断测试的强劲需求和有效治疗乳腺癌的技术进步也是北美乳腺癌治疗市场显著增长的其他因素。

Competitive Analysis

The leading players in the breast cancer therapeutics market include AstraZeneca, Bayer AG, Danaher, Bristol Myers Squibb, Eisai Co., Ltd., Merck & Co., Novartis AG, Novocure, Pfizer Inc., and F. Hoffmann-La Roche AG among others. The leading players in the market are introducing new innovative products in the market to cater to the growing consumer demands. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence.